Runben Biotechnology Co., Ltd. (SHA:603193)
China
· Delayed Price · Currency is CNY 22.37
-0.18 (-0.80%)
At close: Mar 9, 2026
Runben Biotechnology Revenue
Runben Biotechnology had revenue of 342.41M CNY in the quarter ending September 30, 2025, with 16.67% growth. This brings the company's revenue in the last twelve months to 1.52B, up 21.75% year-over-year. In the year 2024, Runben Biotechnology had annual revenue of 1.32B with 27.61% growth.
Revenue (ttm)
1.52B
Revenue Growth
+21.75%
P/S Ratio
5.96
Revenue / Employee
1.65M
Employees
921
Market Cap
9.05B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Baiya Sanitary Products | 3.55B |
| C&S Paper Co.,Ltd | 8.67B |
| Guangdong Marubi Biotechnology | 3.47B |
| Hongmian Zhihui Science and Technology Innovation Co.,Ltd.Guangzhou | 1.98B |
| Hangzhou Haoyue Personal Care | 3.61B |
| Mingchen Health | 1.47B |
| Shanghai Jahwa United | 6.16B |
| Dencare (Chongqing) Oral Care | 1.74B |